Applied Biotechnology Institute, Inc.

1:30 PM - 1:45 PM, Wednesday, June 5,2019 ・ Theater 3
ABI has developed a platform for the high accumulation of recombinant proteins with unique advantages over existing technologies. This includes several applications including: 1) Using the platform to commercialized animal-free pharmaceutical reagents and industrial proteins, 2) Developing oral vaccines for both human and animals, 3) Developing a high intensity natural sweetener. The technology is also well suited to produce antibodies and other protein drugs for which proof-of concept has been demonstrated. ABI is now seeking partners to help commercialize products in the latter stages of development as well as initiate collaborations for new products with partners.